Daavlin NeoLux 3 Series User Manual

MNL-00008 [5] Proprietary and Confidential Page 46 of 55
Skin Type
I
II
III
IV
V
VI
MED RANGE
20-60 mJ
30-75 mJ
40-90 mJ
50-110 mJ
60-120 mJ
70-140 mJ
DOSE LIMITS with WARNING
1400 mJ
1700 mJ
2000 mJ
2500 mJ
2700 mJ
3100 mJ
SYSTEM DOSE LIMITS
1600 mJ
1900 mJ
2200 mJ
2700 mJ
3000 mJ
3400 mJ
23.10 LO Dose Narrow Band UVB Clearing Phase Protocols: 11011, 3/week, 2/week
Maximum Number of Treatments = 29
ALL SKIN TYPES, ALL SCHEDULES
% of
MED
% INCREASE OVER PREVIOUS DOSE
TREATMENT #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
PRIMARY DOSE (MILLIJOULES)
30
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
0
0
0
0
0
0
0
0
% OF PRIMARY DOSE
SECONDARY DOSE (MILLIJOULES)
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
23.11 LO Dose Narrow Band UVB Maintenance Phase Protocols: 1/WEEK
Maximum Number of Treatments = 4
ALL SKIN TYPES: Dose should be held steady at last clearance phase dose.
23.12 LO Dose Narrow Band UVB Treatment Limits for Maintenance & As Required Protocols
Skin Type
I
II
III
IV
V
VI
MED RANGE
50-300 mJ
100-400 mJ
150-500 mJ
200-600 mJ
250-700 mJ
300-800 mJ
DOSE LIMITS with WARNING
800 mJ
1100 mJ
1300 mJ
1600 mJ
1800 mJ
2100 mJ
SYSTEM DOSE LIMITS
1000 mJ
1400 mJ
1700 mJ
2000 mJ
2300 mJ
2700 mJ
23.13 HI Dose Narrow Band UVB Clearing Phase Protocols:
11011, 3/week, 2/week

Daavlin NeoLux 3 Series Specifications

General

Brand	Daavlin
Model	NeoLux 3 Series
Category	Medical Equipment
Language	English